Buprenorphine Hcl And Naloxone Hcl Tablet
FDA Label NDC 63629-7269

56 label sections · Submitted to the FDA by Bryant Ranch Prepack · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bryant Ranch Prepack for the product Buprenorphine Hcl And Naloxone Hcl (NDC 63629-7269). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1  indications and usage, 2.2 important dosage and administration information, 2.3 patient access to naloxone for the emergency treatment of opioid overdose, 2.4 maintenance, 2.5 method of administration, 2.6 clinical supervision, 2.7 unstable patients, 2.8 discontinuing treatment, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Package Label.Principal Display Panel

Buprenorphine and Naloxone Sublingual 8mg/2mg Tablets

Label (Lbl636295074)

Label (Lbl636295074)

Buprenorphine and Naloxone Sublingual 2mg/0.5mg Tablets

Label (Lbl636297269)

Label (Lbl636297269)

* Please review the disclaimer below.